These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8675666)

  • 1. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.
    Niimura F; Labosky PA; Kakuchi J; Okubo S; Yoshida H; Oikawa T; Ichiki T; Naftilan AJ; Fogo A; Inagami T
    J Clin Invest; 1995 Dec; 96(6):2947-54. PubMed ID: 8675666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenesis and renovascular development in angiotensinogen-deficient mice.
    Nagata M; Tanimoto K; Fukamizu A; Kon Y; Sugiyama F; Yagami K; Murakami K; Watanabe T
    Lab Invest; 1996 Nov; 75(5):745-53. PubMed ID: 8941219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy.
    Miyazaki Y; Tsuchida S; Fogo A; Ichikawa I
    Kidney Int; 1999 May; 55(5):1683-95. PubMed ID: 10231430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption.
    Okubo S; Niimura F; Matsusaka T; Fogo A; Hogan BL; Ichikawa I
    Kidney Int; 1998 Mar; 53(3):617-25. PubMed ID: 9507206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
    Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney.
    Yoo KH; Wolstenholme JT; Chevalier RL
    Pediatr Res; 1997 Nov; 42(5):588-92. PubMed ID: 9357928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensinogen-deficient mice with hypotension.
    Tanimoto K; Sugiyama F; Goto Y; Ishida J; Takimoto E; Yagami K; Fukamizu A; Murakami K
    J Biol Chem; 1994 Dec; 269(50):31334-7. PubMed ID: 7989296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction.
    Shin GT; Kim WH; Yim H; Kim MS; Kim H
    Kidney Int; 2005 Mar; 67(3):897-908. PubMed ID: 15698429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.
    Lee LK; Meyer TW; Pollock AS; Lovett DH
    J Clin Invest; 1995 Aug; 96(2):953-64. PubMed ID: 7635988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice.
    Kihara M; Umemura S; Sumida Y; Yokoyama N; Yabana M; Nyui N; Tamura K; Murakami K; Fukamizu A; Ishii M
    Kidney Int; 1998 Mar; 53(3):548-55. PubMed ID: 9507198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice.
    Kobori H; Ozawa Y; Satou R; Katsurada A; Miyata K; Ohashi N; Hase N; Suzaki Y; Sigmund CD; Navar LG
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F938-45. PubMed ID: 17634399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver angiotensinogen is the primary source of renal angiotensin II.
    Matsusaka T; Niimura F; Shimizu A; Pastan I; Saito A; Kobori H; Nishiyama A; Ichikawa I
    J Am Soc Nephrol; 2012 Jul; 23(7):1181-9. PubMed ID: 22518004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes.
    Tsuchida S; Matsusaka T; Chen X; Okubo S; Niimura F; Nishimura H; Fogo A; Utsunomiya H; Inagami T; Ichikawa I
    J Clin Invest; 1998 Feb; 101(4):755-60. PubMed ID: 9466969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone.
    Yang CW; Striker GE; Chen WY; Kopchick JJ; Striker LJ
    Lab Invest; 1997 Apr; 76(4):467-76. PubMed ID: 9111509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.
    Fern RJ; Yesko CM; Thornhill BA; Kim HS; Smithies O; Chevalier RL
    J Clin Invest; 1999 Jan; 103(1):39-46. PubMed ID: 9884332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs.
    Gu JW; Wang J; Stockton A; Lokitz B; Henegar L; Hall JE
    Kidney Int; 2004 Aug; 66(2):713-21. PubMed ID: 15253726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
    Ma LJ; Nakamura S; Whitsitt JS; Marcantoni C; Davidson JM; Fogo AB
    Kidney Int; 2000 Dec; 58(6):2425-36. PubMed ID: 11115076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.